Departments of Neurology, Hadassah-Hebrew University Medical Center, P.O. Box 12000, 91120, Jerusalem, Israel.
Department of Stroke and Neurology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Cardiovasc Intervent Radiol. 2022 Jun;45(6):826-833. doi: 10.1007/s00270-022-03115-0. Epub 2022 Mar 16.
Hemorrhagic transformation (HT) following cerebral endovascular thrombectomy (EVT) for large vessel occlusion (LVO) in acute ischemic stroke is associated with poor outcome. Recent studies have shown that EVT can be efficacious in imaging-selected patients as late as 6-24 h from onset (late time window; LTW). We sought to determine predictors and prognostic implications of HT following EVT in LTW.
Consecutive patients undergoing EVT for LVO were recruited into a prospective multicenter database. HT was divided into petechial hemorrhagic-infarction and parenchymal hematoma (PH) type 1 or 2 defined as confluent hemorrhage covering < or > than 1/3 of the infarct volume, respectively. Multivariate analyses were performed to determine variables associated with HT subtypes.
Among 611 patients included (mean age 70.5 ± 12.5 years; median NIHSS 16), 115 (18.8%) had HT and 33 of them (5.4%) had PH2. Independent PH2 predictors included failed recanalization (OR 7.0, 95% CI 2.3-21.6), longer time from symptom onset to admission (OR 1.002 per minute 95% CI 1.001-1.003) and hyperlipidemia (OR 3.12; 95%CI 1.12-8.7). HT was not associated with outcome. In contrast, PH2 patients had lower favorable outcome rates (14.3 vs 41.6%, p = 0.004) and higher mortality rates (39 vs 17%, p = 0.001). Patients who underwent EVT in the late versus early window had similar PH2 rates (4.5 vs 6.7%, p = 0.27). In multivariate models, PH2 tripled the odds of both 90-day poor outcome (OR 3.1, 95% CI 1.01-9.5) and 90-day mortality (OR 3.2, 95% CI 1.4-7.3).
PH2 following EVT is associated with increased mortality and unfavorable outcome rates. Rates of PH2 are not different between LTW patients and those treated < 6 h from symptom onset.
脑血管内血栓切除术(EVT)治疗大动脉闭塞(LVO)引起的急性缺血性卒中后出血性转化(HT)与预后不良有关。最近的研究表明,在影像学选择的患者中,EVT 可以在发病后 6-24 小时(晚期时间窗;LTW)内有效。我们旨在确定 LTW 中 EVT 后 HT 的预测因素和预后意义。
连续招募接受 LVO EVT 的患者进入前瞻性多中心数据库。HT 分为斑点状出血性梗死和实质血肿(PH)1 型或 2 型,分别定义为覆盖梗死体积>1/3 或<1/3 的融合性出血。进行多变量分析以确定与 HT 亚型相关的变量。
在 611 例患者中(平均年龄 70.5±12.5 岁;NIHSS 中位数 16),115 例(18.8%)发生 HT,其中 33 例(5.4%)发生 PH2。独立的 PH2 预测因素包括再通失败(OR 7.0,95%CI 2.3-21.6)、从症状发作到入院的时间延长(OR 1.002/分钟,95%CI 1.001-1.003)和高脂血症(OR 3.12;95%CI 1.12-8.7)。HT 与结局无关。相比之下,PH2 患者的良好结局率较低(14.3% vs. 41.6%,p=0.004),死亡率较高(39% vs. 17%,p=0.001)。晚期与早期窗口行 EVT 的患者 PH2 发生率相似(4.5% vs. 6.7%,p=0.27)。在多变量模型中,PH2 使 90 天不良结局(OR 3.1,95%CI 1.01-9.5)和 90 天死亡率(OR 3.2,95%CI 1.4-7.3)的可能性增加两倍。
EVT 后 PH2 与死亡率和不良结局发生率增加有关。LTW 患者与发病后<6 小时治疗的患者 PH2 发生率无差异。